A Comparison of Rocuronium 0.3 mg/kg, and 0.9 mg/kg for Induction of Anesthesia in Elderly Patients.
Status:
Completed
Trial end date:
2021-05-25
Target enrollment:
Participant gender:
Summary
The number of elderly patients above 80 years is increasing and a large proportion of these
patients will require surgery and anesthesia.
During anesthesia neuromuscular blocking agents (NMBA) are administered to facilitate
intubating conditions and reduce the trauma to the larynx and vocal cords. There is a risk of
residual neuromuscular block when using NMBAs like rocuronium.
The aim of this study is to determine the onset time, duration of action and effect on
intubating conditions after rocuronium 0.3 mg/kg and 0.9 mg/kg in patients with age ≥ 80
years.